Effect of GLP-1 receptor agonists on bone mineral density, bone metabolism markers, and fracture risk in type 2 diabetes: a systematic review and meta-analysis.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Effect of GLP-1 receptor agonists on bone mineral density, bone metabolism markers, and fracture risk in type 2 diabetes: a systematic review and meta-analysis.
- Published In:
- Acta diabetologica, 62(5), 589-606 (2025)
- Authors:
- Tan, Yimei, Liu, Shuanghua, Tang, Qizhi
- Database ID:
- RPEP-13759
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-13759APA
Tan, Yimei; Liu, Shuanghua; Tang, Qizhi. (2025). Effect of GLP-1 receptor agonists on bone mineral density, bone metabolism markers, and fracture risk in type 2 diabetes: a systematic review and meta-analysis.. Acta diabetologica, 62(5), 589-606. https://doi.org/10.1007/s00592-025-02468-5
MLA
Tan, Yimei, et al. "Effect of GLP-1 receptor agonists on bone mineral density, bone metabolism markers, and fracture risk in type 2 diabetes: a systematic review and meta-analysis.." Acta diabetologica, 2025. https://doi.org/10.1007/s00592-025-02468-5
RethinkPeptides
RethinkPeptides Research Database. "Effect of GLP-1 receptor agonists on bone mineral density, b..." RPEP-13759. Retrieved from https://rethinkpeptides.com/research/tan-2025-effect-of-glp1-receptor
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.